These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33114456)

  • 1. Identification of Novel Mutations and Expressions of
    Islam F; Pillai S; Gopalan V; Lam AK
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33114456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma.
    Welander J; Andreasson A; Brauckhoff M; Bäckdahl M; Larsson C; Gimm O; Söderkvist P
    Endocr Relat Cancer; 2014 Jun; 21(3):495-504. PubMed ID: 24741025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas.
    Toledo RA; Qin Y; Srikantan S; Morales NP; Li Q; Deng Y; Kim SW; Pereira MA; Toledo SP; Su X; Aguiar RC; Dahia PL
    Endocr Relat Cancer; 2013 Jun; 20(3):349-59. PubMed ID: 23533246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.
    Comino-Méndez I; de Cubas AA; Bernal C; Álvarez-Escolá C; Sánchez-Malo C; Ramírez-Tortosa CL; Pedrinaci S; Rapizzi E; Ercolino T; Bernini G; Bacca A; Letón R; Pita G; Alonso MR; Leandro-García LJ; Gómez-Graña A; Inglada-Pérez L; Mancikova V; Rodríguez-Antona C; Mannelli M; Robledo M; Cascón A
    Hum Mol Genet; 2013 Jun; 22(11):2169-76. PubMed ID: 23418310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EPAS1-related pheochromocytoma/paraganglioma.
    Alzahrani AS; Alswailem M; Buffet A; Alghamdi B; Alobaid L; Alsagheir O; Al-Hindi H; Pacak K
    Endocr Relat Cancer; 2024 Aug; 31(8):. PubMed ID: 38767322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative immunohistochemical study of phaeochromocytomas and paragangliomas.
    Fraga M; García-Caballero T; Antúnez J; Couce M; Beiras A; Forteza J
    Histol Histopathol; 1993 Jul; 8(3):429-36. PubMed ID: 8358154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas.
    Lam KY; Lo CY; Wat NM; Luk JM; Lam KS
    J Clin Pathol; 2001 Jun; 54(6):443-8. PubMed ID: 11376017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF2 and endocrine neoplasia: an evolving story.
    Maher ER
    Endocr Relat Cancer; 2013 Jun; 20(3):C5-7. PubMed ID: 23653463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas.
    Remacha L; Pirman D; Mahoney CE; Coloma J; Calsina B; Currás-Freixes M; Letón R; Torres-Pérez R; Richter S; Pita G; Herráez B; Cianchetta G; Honrado E; Maestre L; Urioste M; Aller J; García-Uriarte Ó; Gálvez MÁ; Luque RM; Lahera M; Moreno-Rengel C; Eisenhofer G; Montero-Conde C; Rodríguez-Antona C; Llorca Ó; Smolen GA; Robledo M; Cascón A
    Am J Hum Genet; 2019 Apr; 104(4):651-664. PubMed ID: 30929736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Analysis of Pheochromocytoma and Paraganglioma Complicating Cyanotic Congenital Heart Disease.
    Ogasawara T; Fujii Y; Kakiuchi N; Shiozawa Y; Sakamoto R; Ogawa Y; Ootani K; Ito E; Tanaka T; Watanabe K; Yoshida Y; Kimura N; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2545-2555. PubMed ID: 35730597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression profile of alternatively spliced neuronal c-src RNA distinguishes between human tumours of the sympatho-adrenal lineage.
    Ortoft E; Bjelfman C; Hedborg F; Grimelius L; Påhlman S
    Int J Cancer; 1995 Jan; 60(1):38-44. PubMed ID: 7529211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
    Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
    Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic diagnosis of phaeochromocytomas and paragangliomas].
    Cardot-Bauters C; Ainaouï M; Coppin L; Pigny P
    Presse Med; 2014 Apr; 43(4 Pt 1):460-7. PubMed ID: 24612707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas.
    Bechmann N; Moskopp ML; Ullrich M; Calsina B; Wallace PW; Richter S; Friedemann M; Langton K; Fliedner SMJ; Timmers HJLM; Nölting S; Beuschlein F; Fassnacht M; Prejbisz A; Pacak K; Ghayee HK; Bornstein SR; Dieterich P; Pietzsch J; Wielockx B; Robledo M; Qin N; Eisenhofer G
    Endocr Relat Cancer; 2020 Nov; 27(11):625-640. PubMed ID: 33112842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15 YEARS OF PARAGANGLIOMA: The association of pituitary adenomas and phaeochromocytomas or paragangliomas.
    O'Toole SM; Dénes J; Robledo M; Stratakis CA; Korbonits M
    Endocr Relat Cancer; 2015 Aug; 22(4):T105-22. PubMed ID: 26113600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phaeochromocytomas and paragangliomas: A difference in disease behaviour and clinical outcomes.
    Ezzat Abdel-Aziz T; Prete F; Conway G; Gaze M; Bomanji J; Bouloux P; Khoo B; Caplin M; Mushtaq I; Smart J; Kurzawinski TR
    J Surg Oncol; 2015 Oct; 112(5):486-91. PubMed ID: 26337393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma.
    Jiang J; Zhang J; Pang Y; Bechmann N; Li M; Monteagudo M; Calsina B; Gimenez-Roqueplo AP; Nölting S; Beuschlein F; Fassnacht M; Deutschbein T; Timmers HJLM; Åkerström T; Crona J; Quinkler M; Fliedner SMJ; Liu Y; Guo J; Li X; Guo W; Hou Y; Wang C; Zhang L; Xiao Q; Liu L; Gao X; Burnichon N; Robledo M; Eisenhofer G
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32750708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stathmin immunoreactivity in phaeochromocytomas and paragangliomas: differential expression between benign and malignant neoplasms.
    Lin WC; Chen SC; Chuang YT; Kuo KL; Huang KH
    Asian J Surg; 2011 Jan; 34(1):15-22. PubMed ID: 21515208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).
    Kaltsas GA; Papadogias D; Grossman AB
    Front Horm Res; 2004; 31():61-75. PubMed ID: 14674305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.